Neddylation inactivation represses androgen receptor transcription and inhibits growth, survival and invasion of prostate cancer cells
Androgen receptor (AR) and its constitutively active variants (AR-Vs) have been extensively implicated in the progression and recurrence of prostate cancer, making them attractive targets in the treatment of this disease. Whether and how neddylation modification regulates AR, and the therapeutic imp...
Main Authors: | Xiaochen Zhou, Sumin Han, Kari Wilder-Romans, Grace Y. Sun, Hong Zhu, Xiaoqiang Liu, Mingjia Tan, Gongxian Wang, Felix Y. Feng, Yi Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-04-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558619303720 |
Similar Items
-
Targeting Protein Neddylation to Inactivate Cullin-RING Ligases by Gossypol: A Lucky Hit or a New Start?
by: Yu Q, et al.
Published: (2021-01-01) -
Decipher the role of NEDDylation in poly-Q expansion androgen receptor
by: Tsai, Sin-Ying, et al.
Published: (2019) -
Dissecting the roles of the androgen receptor in prostate cancer from molecular perspectives
by: Jieping Hu, et al.
Published: (2017-04-01) -
Repressive effects of resveratrol on androgen receptor transcriptional activity.
by: Wen-feng Shi, et al.
Published: (2009-10-01) -
Tzfp represses the androgen receptor in mouse testis.
by: Kari Furu, et al.
Published: (2013-01-01)